Vivos (RDGL) EBT Margin (QoQ) (2011 - 2025)
Vivos (RDGL) EBT Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.74 Bn | 197.14 Bn | 7.27 Bn |
| 2 | Stryker | 127.22 Bn | 123.75 Bn | 4.50 Bn |
| 3 | Medtronic | 119.44 Bn | 110.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.78 Bn | 74.24 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.81 Bn | 47.56 Bn | 1.35 Bn |
| 6 | Dexcom | 34.98 Bn | 33.03 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.79 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn |
| 9 | Steris | 23.24 Bn | 22.76 Bn | 684.20 Mn |
| 10 | Vivos | 23.99 Mn | 22.44 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | -2.27 Mn |
| Jun 30, 2025 | -118,283.00 |
| Mar 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | -397,898.00 |
| Sep 30, 2024 | -1.28 Mn |
| Jun 30, 2024 | 868,266.00 |
| Sep 30, 2023 | 434,659.00 |
| Jun 30, 2023 | -974,638.00 |
| Mar 31, 2023 | 671,924.00 |
| Dec 31, 2022 | -659,533.00 |
| Sep 30, 2022 | 323,782.00 |
| Jun 30, 2022 | -211,648.00 |
| Dec 31, 2019 | -2.52 Mn |
| Sep 30, 2016 | 9.93 Mn |
| Jun 30, 2016 | 4.00 Mn |
| Jun 30, 2014 | -458,465.00 |
| Mar 31, 2013 | 350,969.00 |
| Dec 31, 2012 | -232,966.00 |
| Sep 30, 2012 | 0.00 |